BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8639853)

  • 1. Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity.
    Broxterman HJ; Sonneveld P; Feller N; Ossenkoppele GJ; Währer DC; Eekman CA; Schoester M; Lankelma J; Pinedo HM; Löwenberg B; Schuurhuis GJ
    Blood; 1996 Jun; 87(11):4809-16. PubMed ID: 8639853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?
    Broxterman HJ; Sonneveld P; Pieters R; Lankelma J; Eekman CA; Loonen AH; Schoester M; Ossenkoppele GJ; Löwenberg B; Pinedo HM; Schuurhuis GJ
    Leukemia; 1999 Feb; 13(2):258-65. PubMed ID: 10025900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of medium exchange is associated with a decrease in function but not expression of the P-glycoprotein pump in leukaemic cells.
    Hegewisch-Becker S; Faltz C; Hossfeld DK
    Eur J Haematol; 1996; 56(1-2):12-22. PubMed ID: 8599988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia.
    Ross DD; Wooten PJ; Sridhara R; Ordóñez JV; Lee EJ; Schiffer CA
    Blood; 1993 Aug; 82(4):1288-99. PubMed ID: 8102561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study.
    Ivy SP; Olshefski RS; Taylor BJ; Patel KM; Reaman GH
    Blood; 1996 Jul; 88(1):309-18. PubMed ID: 8704189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.
    Feller N; Kuiper CM; Lankelma J; Ruhdal JK; Scheper RJ; Pinedo HM; Broxterman HJ
    Br J Cancer; 1995 Sep; 72(3):543-9. PubMed ID: 7669559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells.
    Michieli M; Damiani D; Ermacora A; Raspadori D; Michelutti A; Grimaz S; Fanin R; Russo D; Lauria F; Masolini P; Baccarani M
    Br J Haematol; 1997 Feb; 96(2):356-65. PubMed ID: 9029025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
    Tsimberidou AM; Paterakis G; Androutsos G; Anagnostopoulos N; Galanopoulos A; Kalmantis T; Meletis J; Rombos Y; Sagriotis A; Symeonidis A; Tiniakou M; Zoumbos N; Yataganas X
    Leuk Res; 2002 Feb; 26(2):143-54. PubMed ID: 11755464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation.
    Nielsen D; Maare C; Eriksen J; Litman T; Skovsgaard T
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1050-7. PubMed ID: 11704330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type.
    Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
    Cancer Chemother Pharmacol; 1994; 34(4):307-16. PubMed ID: 7913420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenografts.
    Broxterman HJ; Feller N; Kuiper CM; Boven E; Versantvoort CH; Teerlink T; Pinedo HM; Lankelma J
    Int J Cancer; 1995 Jun; 61(6):880-6. PubMed ID: 7790125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia.
    Albertioni F; Gruber A; Areström I; Vitols S
    Med Oncol; 1995 Jun; 12(2):79-86. PubMed ID: 8535665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines.
    Bailly JD; Muller C; Jaffrézou JP; Demur C; Gassar G; Bordier C; Laurent G
    Leukemia; 1995 May; 9(5):799-807. PubMed ID: 7769842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia.
    Legrand O; Simonin G; Beauchamp-Nicoud A; Zittoun R; Marie JP
    Blood; 1999 Aug; 94(3):1046-56. PubMed ID: 10419897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemia.
    van der Pol MA; Pater JM; Feller N; Westra AH; van Stijn A; Ossenkoppele GJ; Broxterman HJ; Schuurhuis GJ
    Leukemia; 2001 Oct; 15(10):1554-63. PubMed ID: 11587213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
    den Boer ML; Pieters R; Kazemier KM; Rottier MM; Zwaan CM; Kaspers GJ; Janka-Schaub G; Henze G; Creutzig U; Scheper RJ; Veerman AJ
    Blood; 1998 Mar; 91(6):2092-8. PubMed ID: 9490695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
    Maslak P; Hegewisch-Becker S; Godfrey L; Andreeff M
    Cytometry; 1994 Sep; 17(1):84-93. PubMed ID: 8001461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of daunorubicin cellular resistance by combination of P-glycoprotein blockers acting on drug efflux and intracellular drug sequestration in Golgi vesicles.
    Merlin JL; Bour-Dill C; Marchal S; Ramacci C; Poullain MG; Giroux B
    Cytometry; 2000 Sep; 41(1):62-72. PubMed ID: 10942898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells.
    Nielsen D; Eriksen J; Maare C; Friche E; Skovsgaard T
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):453-60. PubMed ID: 12107549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between anthracyclines and rhodamine-123 accumulation in chronic lymphoid leukemia: effect of cyclosporin A and verapamil.
    Maia RC; Vasconcelos FC; Harab RC; Coelho AM; Dobbin JA; Rumjanek VM
    Tumour Biol; 1998; 19(1):41-51. PubMed ID: 9422081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.